Q32 Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	33.79	29.82	-47.73	-53.74	-42.81	-37.56
Depreciation & Amortization	0.36	0.39	0.49	0.5	0.37	0.05
Other Amortization	0.18	0.18	0.19	0.09	0.1	0.1
Loss (Gain) From Sale of Assets	-11.74	-11.74	-	-	0.02	-
Loss (Gain) From Sale of Investments	-	0.07	0.45	-	-	-
Loss (Gain) on Equity Investments	-	-	1.63	-	-	-
Stock-Based Compensation	5.88	5.26	4.39	1.43	1.24	0.75
Other Operating Activities	-53.08	-53.49	-17.49	6.74	3.18	-
Change in Accounts Payable	0.66	-2.11	-1.04	2.03	-1.24	1.1
Change in Unearned Revenue	-	-	-	-25.85	25.85	-
Change in Other Net Operating Assets	4.13	-1.93	-8.59	50.13	2.34	2.58
Operating Cash Flow	-19.83	-33.54	-67.72	-18.68	-10.96	-32.98
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-	-	-0.08	-0.01	-2.49	-0.16
Sale of Property, Plant & Equipment	7	7	-	-	0.02	-
Investment in Securities	-	-	20	-	-	-
Investing Cash Flow	7	7	19.93	-0.01	-2.47	-0.16
Long-Term Debt Issued	-	-	7	5.5	30	-
Long-Term Debt Repaid	-	-3.13	-	-5.2	-	-
Net Debt Issued (Repaid)	-12.95	-3.13	7	0.3	30	-
Issuance of Common Stock	77.21	-	43.69	0.11	0.07	0.12
Other Financing Activities	-	-	44.44	-	-	-
Financing Cash Flow	64.27	-3.13	95.14	0.41	30.07	20.11
Net Cash Flow	51.44	-29.67	47.35	-18.28	16.65	-13.03
Free Cash Flow	-19.83	-33.54	-67.79	-18.68	-13.44	-33.14
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-36.90%	-62.42%	-	-	-202.10%	-
Free Cash Flow Per Share	-1.33	-2.72	-7.02	-53.52	-1.91	-5.12
Levered Free Cash Flow	19.39	4.52	-37.95	-41.84	-8.73	-
Unlevered Free Cash Flow	19.77	5.03	-37.27	-40.68	-8.83	-
Cash Interest Paid	0.86	0.96	0.86	-	-	-
Change in Working Capital	4.78	-4.04	-9.64	26.32	26.94	3.68

SEC Filings: 10-K · 10-Q